Ny publikation där Attanas teknologi används för att välja huvudkandidaten till en ny antikroppsbaserad antiviral behandling av Hepatit B-infektion

Share this post

We use cookies to improve the functionality, performance, and effectiveness of our website. Detailed information on the use of cookies is provided in our Privacy Policy and Terms of Use. By continuing to use this site, or by clicking “I agree” you consent to the use of cookies.